Insulin-regulated aminopeptidase (IRAP) represents a promising target for the development of a new class of cognitive enhancing agents.
No takes yet. Share an insight, caveat, or question.
IRAP may be a target for cognitive enhancers in animal models; leaves open translation to human cognitive disorders.
Chai et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: